BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15099776)

  • 1. Abnormal uterine bleeding and prognosis of endometrial cancer.
    Kimura T; Kamiura S; Yamamoto T; Seino-Noda H; Ohira H; Saji F
    Int J Gynaecol Obstet; 2004 May; 85(2):145-50. PubMed ID: 15099776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial curettage in abnormal uterine bleeding and efficacy of progestins for control in cases of hyperplasia.
    Mesci-Haftaci S; Ankarali H; Yavuzcan A; Caglar M
    Asian Pac J Cancer Prev; 2014; 15(8):3737-40. PubMed ID: 24870785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
    Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
    Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding.
    Lasmar RB; Barrozo PR; de Oliveira MA; Coutinho ES; Dias R
    J Minim Invasive Gynecol; 2006; 13(5):409-12. PubMed ID: 16962523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A histopathological and immunohistochemistry analysis of endometrial lesions among women presenting with abnormal uterine bleeding.
    Walvir NM; Rana S; Jairajpuri ZS; Jetley S; Nigam A
    J Cancer Res Ther; 2022; 18(6):1474-1484. PubMed ID: 36412397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of delayed diagnosis on established prognostic factors in endometrial cancer.
    Obermair A; Hanzal E; Schreiner-Frech I; Buxbaum P; Bancher-Todesca D; Thoma M; Kurz C; Vavra N; Gitsch G; Sevelda P
    Anticancer Res; 1996; 16(2):947-9. PubMed ID: 8687157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations for postmenopausal uterine bleeding: special considerations for endometrial volume.
    Cho HJ; Lee ES; Lee JY; Hong SN; Ji YI; Kim HY; Kim A
    Arch Iran Med; 2013 Nov; 16(11):665-70. PubMed ID: 24206410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an appropriate cutoff age for sampling the endometrium in premenopausal bleeding?
    Corbacioglu Esmer A; Akbayir O; Goksedef BP; Gunduz N; Kisacık S; Dagdeviren H; Guraslan B; Ark C
    Gynecol Obstet Invest; 2014; 77(1):40-4. PubMed ID: 24334971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women.
    Kodama J; Seki N; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Int J Gynaecol Obstet; 2005 Nov; 91(2):151-6. PubMed ID: 16162346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup.
    Warring SK; Borah B; Moriarty J; Gullerud R; Lemens MA; Destephano C; Sherman ME; Bakkum-Gamez JN
    Gynecol Oncol; 2022 Jan; 164(1):93-97. PubMed ID: 34756471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding.
    Litta P; Merlin F; Saccardi C; Pozzan C; Sacco G; Fracas M; Capobianco G; Dessole S
    Maturitas; 2005 Feb; 50(2):117-23. PubMed ID: 15653009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
    Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portulaca oleracea L. in the treatment of patients with abnormal uterine bleeding: a pilot clinical trial.
    Shobeiri SF; Sharei S; Heidari A; Kianbakht S
    Phytother Res; 2009 Oct; 23(10):1411-4. PubMed ID: 19274703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
    Aquino-Parsons C; Lim P; Wong F; Mildenberger M
    Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding.
    Garcia F; Barker B; Davis J; Shelton T; Harrigill K; Schalk N; Meyer J; Hatch K
    J Reprod Med; 2003 Nov; 48(11):882-8. PubMed ID: 14686021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of endometrial carcinoma: a study of 98 cases].
    Yin LJ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):150-2, 188. PubMed ID: 8354094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory hysteroscopy in evaluation of postmenopausal bleeding].
    Wieser F; Albrecht A; Kurz C; Wenzl R; Nagele F
    Wien Klin Wochenschr; 1999 Apr; 111(7):289-93. PubMed ID: 10355040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after intrauterine morcellation vs hysteroscopic resection of endometrial polyps.
    AlHilli MM; Nixon KE; Hopkins MR; Weaver AL; Laughlin-Tommaso SK; Famuyide AO
    J Minim Invasive Gynecol; 2013; 20(2):215-21. PubMed ID: 23295201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial echo complex thickness in postmenopausal endometrial cancer.
    Chandavarkar U; Kuperman JM; Muderspach LI; Opper N; Felix JC; Roman L
    Gynecol Oncol; 2013 Oct; 131(1):109-12. PubMed ID: 23917081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Nomogram Prediction Model for Endometrial Malignancy in Patients with Abnormal Uterine Bleeding.
    Ruan H; Chen S; Li J; Ma L; Luo J; Huang Y; Ying Q; Zhou J
    Yonsei Med J; 2023 Mar; 64(3):197-203. PubMed ID: 36825346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.